Childhood Cancer Hearing Loss PFDD Meeting (Full Program)
September 13, 2018
The pediatric patient population with chemotherapy-induced hearing loss represents a segment of the cancer survivor community with a severe burden of disease with a great unmet medical need. An externally-led, FDA-approved Patient-Focused Drug Development (PFDD) meeting on September 13, 2018, near Washington, DC will explore these issues in-depth. The half-day meeting follows the FDA model […]
